C.R. Bard CEO Timothy M. Ring Sells 10,228 Shares (BCR)
C.R. Bard (NYSE:BCR) CEO Timothy M. Ring unloaded 10,228 shares of C.R. Bard stock on the open market in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $148.83, for a total transaction of $1,522,233.24. Following the completion of the transaction, the chief executive officer now directly owns 170,233 shares of the company’s stock, valued at approximately $25,335,777. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
C.R. Bard (NYSE:BCR) traded down 0.04% during mid-day trading on Thursday, hitting $149.36. 477,221 shares of the company’s stock traded hands. C.R. Bard has a one year low of $113.52 and a one year high of $154.16. The stock has a 50-day moving average of $148.6 and a 200-day moving average of $144.8. The company has a market cap of $11.147 billion and a P/E ratio of 15.23.
C.R. Bard (NYSE:BCR) last released its earnings data on Thursday, July 24th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.05. The company had revenue of $827.10 million for the quarter, compared to the consensus estimate of $814.58 million. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts expect that C.R. Bard will post $8.31 EPS for the current fiscal year.
BCR has been the subject of a number of recent research reports. Analysts at Bank of America downgraded shares of C.R. Bard from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of C.R. Bard in a research note on Monday, July 28th. They now have a $156.00 price target on the stock. Finally, analysts at Raymond James reiterated an “outperform” rating on shares of C.R. Bard in a research note on Friday, July 25th. They now have a $170.00 price target on the stock, up previously from $155.00. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $144.25.
C. R. Bard, Inc (NYSE:BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.
Receive News & Ratings for CR Bard Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CR Bard Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.